Silencing UBE2C arrests cell cycle progression at the G1/S phases, inhibits cell proliferation in pancreatic ductal adenocarcinoma [34] and blocks the G2/M transition in melanoma [12]. The gene discussed is UBE2C; the disease is melanoma.